Abstract P1-01-01: Circulating tumor cell number and CTC-endocrine therapy index predict clinical outcomes in ER positive metastatic breast cancer patients: Results of the COMETI Phase 2 trial
Paoletti, C, Regan, MM, Liu, MC, Marcom, PK, Hart, LL, Smith, JW, Tedesco, KL, Amir, E, Krop, IE, DeMichele, AM, Goodwin, PJ, Block, M, Aung, K, Cannell, EM, Darga, EP, Baratta, PJ, Brown, ME, McCormack, RT, Hayes, DF
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Published in Cancer research (Chicago, Ill.) (15.02.2017)
Get full text
Journal Article
Abstract P3-05-01: Molecular analysis of cancer tissue, circulating tumor cells (CTC) and cell-free plasma tumor DNA (ptDNA) suggests variable mechanisms of resistance to endocrine therapy (ET) in estrogen receptor (ER) positive metastatic breast cancer (MBC)
Paoletti, C, Aung, K, Cannell, EM, Darga, EP, Chu, D, Kidwell, KM, Thomas, DG, Tokudome, N, Brown, ME, McNutt, LM, Gersch, C, Schott, AF, Park, BH, Robinson, DR, Chinnaiyan, AM, Rae, JM, Hayes, DF
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article
Abstract P2-02-19: Somatic genetic profiling of circulating tumor cells (CTC) in metastatic breast cancer (MBC) patients
Paoletti, C, Cani, AK, Aung, K, Darga, EP, Cannell, EM, Hovelson, DH, Yazdani, M, Blevins, AR, Tokudome, N, Larios, JM, Thomas, DG, Brown, ME, Gersch, C, Schott, AF, Robinson, DR, Chinnaiyan, AM, Bischoff, F, Hayes, DF, Rae, JM, Tomlins, SA
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Published in Cancer research (Chicago, Ill.) (15.02.2016)
Get full text
Journal Article